Show simple item record

dc.contributor.authorAykac, Kubra
dc.contributor.authorOzsurekci, Yasemin
dc.contributor.authorTanir Basaranoglu, Sevgen
dc.date.accessioned2019-12-10T10:37:38Z
dc.date.available2019-12-10T10:37:38Z
dc.date.issued2017
dc.identifier.issn1198-2241
dc.identifier.urihttps://doi.org/10.1155/2017/2614602
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661065/
dc.identifier.urihttp://hdl.handle.net/11655/14015
dc.description.abstractMechanical ventilation is a lifesaving treatment and has complications such as ventilator associated pneumonia (VAP) that lead to high morbidity and mortality. Moreover VAP is the second most common hospital-acquired infection in pediatric intensive care units. Although it is still not well understood, understanding molecular pathogenesis is essential for preventing and treating pneumonia. A lot of microbes are detected as a causative agent of VAP. The most common isolated VAP pathogens in pediatric patients are Staphylococcus aureus, Pseudomonas aeruginosa, and other gram negative bacteria. All of the bacteria have different pathogenesis due to their different virulence factors and host reactions. This review article focused on mechanisms of VAP with molecular pathogenesis of the causative bacteria one by one from the literature. We hope that we know more about molecular pathogenesis of VAP and we can investigate and focus on the management of the disease in near future.
dc.relation.isversionof10.1155/2017/2614602
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleFuture Directions And Molecular Basis Of Ventilator Associated Pneumonia
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalCanadian Respiratory Journal
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume2017
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Files in this item

This item appears in the following Collection(s)

Show simple item record